PMID: 7370919Apr 1, 1980Paper

Histologic features of tumors and the female superiority in survival from malignant melanoma

Cancer
H ShawW H McCarthy

Abstract

The primary tumors of 780 patients with clinical Stage I malignant melanoma were reviewed to seek reasons for the female superiority in survival. Histologic features of tumors believed to be of prognostic significance were examined: tumor thickness, evidence of regression, histogenetic type, and mitotic activity. The average tumor thickness was significantly less in women, due to a preponderance of very thin lesions in women and very thick lesions in men. In both men and women, there proved to be a direct correlation between five-year survival rate and tumor thickness, but women had a higher survival rate than men at each thickness level. These latter two findings, in combination, could contribute to the overall female superiority in survival. No further insight into the sex difference in survival was obtained from the examination of the other histologic features. Although the incidence of partial lesion regression was not markedly different except for very thin lesions. There were no disparities between the sexes in the incidences of histogenetic types or grades of mitotic activity, two histologic features which drew their prognostic significance only from their correlation with tumor thickness.

References

Feb 1, 1977·The Australian and New Zealand Journal of Surgery·P IronsideB K Rank
Jun 1, 1978·The Australian and New Zealand Journal of Surgery·J TonakH Groitl
Sep 1, 1979·Histopathology·V J McGovernG A Farago
Nov 1, 1977·The British Journal of Surgery·G W MiltonW H McCarthy
Mar 1, 1978·Plastic and Reconstructive Surgery·A Breslow, S D Macht
Aug 1, 1978·Cancer·H M ShawW H McCarthy
Apr 1, 1978·The Australasian Journal of Dermatology·N C Davis
Apr 1, 1975·Pathology·V J McGovern
Oct 1, 1974·American Journal of Surgery·M G Hansen, A B McCarten
Dec 1, 1969·The Australasian Journal of Dermatology·G L BeardmoreA F Burry
May 1, 1967·Archives of Internal Medicine·L NathansonS Farber
Feb 15, 1963·Annals of the New York Academy of Sciences·L P WHITE

❮ Previous
Next ❯

Citations

Nov 1, 1992·Seminars in Surgical Oncology·C M Balch
Jan 1, 1989·Journal of Cancer Research and Clinical Oncology·B BiessA Peters
Jan 25, 2008·Gender Medicine·Harry Dao, Rebecca A Kazin
Jul 25, 2006·Nature Reviews. Cancer·Andrew I Minchinton, Ian F Tannock
Oct 24, 2000·Clinical and Experimental Dermatology·R M MacKie
May 2, 2002·International Journal of Dermatology·Vivian ZemelmanA Kirschbaum
Apr 25, 2006·Annals of Surgery·Charles R ScogginsUNKNOWN Sunbelt Melanoma Trial
Jun 1, 1995·Pigment Cell Research·V MorvilloJ Mordoh
Jun 24, 2008·World Journal of Surgical Oncology·Marília B Espíndola, Oly C Corleta
Jul 3, 1993·BMJ : British Medical Journal·I Jatoi, M E Gore
Nov 6, 2009·Actas dermo-sifiliográficas·C RequenaC Guillén
Sep 1, 1993·Journal of the American Academy of Dermatology·F H RampenC H Nijs
Mar 1, 1992·Journal of the American Academy of Dermatology·K A VossaertM Levenstein
Nov 1, 1985·Journal of the American Academy of Dermatology·J W KellyR W Sagebiel
Feb 1, 1990·Journal of the American Academy of Dermatology·V C Ho, A J Sober
Aug 1, 1986·Journal of the American Academy of Dermatology·D RadermanM Ben-Bassat
May 1, 1996·Journal of the American Academy of Dermatology·J B Smith, N A Fenske
Jun 1, 1984·European Journal of Cancer & Clinical Oncology·P G GillD J Horsfall
Jul 1, 1982·Histopathology·V J McGovernW H McCarthy
Aug 1, 1982·The Australian and New Zealand Journal of Surgery·W H McCarthyG Roberts
Jul 1, 1985·Statistics in Medicine·N CascinelliR Bufalino
Aug 15, 1981·International Journal of Cancer. Journal International Du Cancer·H M Shaw, G W Milton
Apr 1, 1981·The Journal of Dermatologic Surgery and Oncology·J LevineM M Mintzis
Sep 1, 1983·Histopathology·V J McGovernG W Milton
Sep 1, 1983·Histopathology·V J McGovernG W Milton
Jan 15, 1983·International Journal of Cancer. Journal International Du Cancer·H K SilverJ J Spinelli
Apr 1, 1982·Journal of Cutaneous Pathology·V J McGovern
Apr 6, 2004·Facial Plastic Surgery Clinics of North America·Ashley A SmithScott W Fosko
Apr 1, 1985·Pathology·E Finckh, T Jelihovsky
Apr 1, 1985·Pathology·P J Heenan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.